OTC VAGINAL DRUG PRODUCT MONOGRAPH PROPOSAL WITHDRAWN BY FDA
This article was originally published in The Rose Sheet
OTC VAGINAL DRUG PRODUCT MONOGRAPH PROPOSAL WITHDRAWN BY FDA in a notice published in the Feb. 3 Federal Register. The agency said it has decided to withdraw an October 1983 advance notice of proposed rulemaking that would have been the basis for a monograph covering over-the-counter vaginal drug products after determining that "some of the recommended labeling indications and ingredients used for minor irritation, itching or soreness are not unique to the vaginal area and are already being considered" in other OTC rulemakings.
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
The National Advertising Division concludes that by claiming the Schick Intuition Plus razor "lathers, shaves and moisturizes in one easy step," Energizer Personal Care is implying a long-term post-shave benefit comparable to that awarded by leave-on moisturizer, which is not supported by the company's evidence